Short answer · Medically reviewed summary · Last updated: 2026-04-06
Peripheral neuropathy is a highly prevalent condition, with estimates suggesting that approximately 2.4% of the general population and up to 8% of individuals over age 55 are affected by some form of nerve damage. Prevalence and Classification While the term Peripheral Neuropathy encompasses a broad spectrum of over 100 different types, it is generally considered a common condition rather than a rare disease in its aggregate form. However, specific subtypes—such as hereditary motor and sensory neuropathies (Charcot-Marie-Tooth disease)—are classified as rare.
1 people with Peripheral Neuropathy have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Peripheral Neuropathy?
Prevalence of Peripheral Neuropathy: how many people are affected worldwide, differences by sex and region, with sources.
Peripheral neuropathy is a highly prevalent condition, with estimates suggesting that approximately 2.4% of the general population and up to 8% of individuals over age 55 are affected by some form of nerve damage.
Prevalence and Classification
While the term Peripheral Neuropathy encompasses a broad spectrum of over 100 different types, it is generally considered a common condition rather than a rare disease in its aggregate form. However, specific subtypes—such as hereditary motor and sensory neuropathies (Charcot-Marie-Tooth disease)—are classified as rare. Because Peripheral Neuropathy is often secondary to other underlying systemic conditions like diabetes mellitus, prevalence rates are heavily skewed by the global burden of those chronic illnesses.
Demographics and Onset
The incidence of Peripheral Neuropathy increases significantly with age, making it predominantly an adult-onset condition. While both males and females are affected, some studies suggest a slightly higher prevalence in men, particularly regarding diabetic-related nerve damage. Geographic and ethnic variations are largely driven by the prevalence of associated risk factors, such as metabolic syndrome and nutritional deficiencies, rather than inherent genetic susceptibility across most populations.
Challenges in Data Collection
Accurate epidemiological data for Peripheral Neuropathy is notoriously difficult to establish. Many cases remain underdiagnosed or misdiagnosed, especially in early stages where symptoms like mild tingling or numbness are overlooked. Furthermore, the lack of a standardized global registry means that many mild cases never enter clinical statistics. At DiseaseMaps.org, our community of 169 members provides a vital real-world perspective, highlighting the diversity of experiences that formal clinical data often fails to capture. By sharing their lived experiences, members help bridge the gap between abstract prevalence statistics and the daily reality of managing Peripheral Neuropathy.
Medical Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Neuropathy Association (Foundation for Peripheral Neuropathy)
Posted Dec 1, 2019 by viva.dana 2500
